Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis

Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis

Autor Marques, MPD Google Scholar
Takayanagui, O. M. Google Scholar
Bonato, P. S. Google Scholar
Santos, SRCJ Google Scholar
Lanchote, V. L. Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
Resumo The enantioselectivity of the kinetic disposition of albendazole sulfoxide (ASOX) was investigated in 18 patients with neurocysticercosis treated with a multiple dose regimen of albendazole for 8 days (5 mg/kg every 8 h). Serial blood samples were collected on the eighth day of treatment during the last dose interval, with prorogation up to 12 h. Albendazole sulfone (ASON) and enantiomers of ASOX were analyzed in plasma samples by HPLC using a Chiralpak(R) AD column and detection by fluorescence. the pharmacokinetic parameters showing statistically significant differences between the (+) ASOX and (-) ASOX enantiomers are presented as respective means (95% CI) as follows: maximum plasma concentration, C-max = 301.6 (179.7-423.5) vs 54.9 (21.9-87.9) ng.ml(-1); elimination half-life, t(1/2) = 5.2 (4.1-6.3) vs 3.3 (2.8-3.8) h, area under the plasma concentration-time curve, AUC(ss)(0-8) - 1719.2 (978.62-459.8) vs 261.4 (102.9-419.8) ng.h.ml(-1) and apparent clearance, Cl/fm = 5.8 (3.8-7.8) vs 54.0 (35.2-72.7) l.h(-1).kg(-1). the mean value of 9.2 (7.6-10.9) for the AUC((+)(0-8)-ASOX)/AUC((-)(0-8)-ASOX) ratio demonstrated plasma accumulation of the (+) enantiomer. Sulfone formation capacity, expressed by the AUC(ss)(0-8) ratio ASON/ASOX + ASON, was 8.0 (7.0-8.9). the present data indicate enantioselectivity in the kinetic disposition of ASOX in patients with neurocysticercosis. Chirality 11:218-223, 1999. (C) 1999 Wiley-Liss, Inc.
Palavra-chave albendazole sulfoxide
enantioselectivity, pharmacokinetics, cysticercosis, metabolism
patient
Idioma Inglês
Data de publicação 1999-01-01
Publicado em Chirality. New York: Wiley-liss, v. 11, n. 3, p. 218-223, 1999.
ISSN 0899-0042 (Sherpa/Romeo, fator de impacto)
Publicador Wiley-Blackwell
Extensão 218-223
Fonte http://dx.doi.org/10.1002/(SICI)1520-636X(1999)11:3<218
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:000078845200008
Endereço permanente http://repositorio.unifesp.br/handle/11600/26004

Exibir registro completo




Arquivo

Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta